Clinical Trial Update: Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative radiotherapy combined with SOX (S-1 and oxaliplatin), apatinib, and camrelizumab for gastric and gastroesophageal junctio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma | Phase 2 | Status: RECRUITING